Search

everythinglearnresearchcommunity

for

Search:↓

A new genetic variant causes BRESHECK syndrome by disrupting cell growth and stress response.

Dutasteride works better than finasteride for hair loss and has mild, reversible side effects.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Combining methotrexate with low-dose prednisone is more effective for hair regrowth in alopecia areata totalis.

WYE-130600 may cause skin thickening and irritation.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Tridax procumbens is effective for wound healing.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

Secukinumab effectively treated a difficult case of folliculitis decalvans.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Alkylating agents can kill cancer cells but may cause skin and allergic reactions.

Bicalutamide shows promise for treating female hair loss.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Low-dose methotrexate effectively regrows hair in many alopecia areata patients but can cause some side effects.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

The new drug carriers show promise for better targeting and treating ovarian cancer.

A man had a rare skin reaction from a hair loss medication, which improved after stopping the drug.

Botulinum A toxin injections reduced pain and promoted hair regrowth in a woman with a rare form of alopecia areata.

Both brands of biotin and dexpanthenol injections improved hair loss, with Bayer also increasing the ratio of thick to thin hairs.